QUESTIONS / STRAIGHT ANSWERS
The Longevity Shelf FAQ
Eight common questions, answered from the composed literature without a protocol, pitch, or promise.
What is NAD supplement used for?
NAD+ products and the precursors NMN and NR are marketed around cellular energy, healthy aging, and metabolic function. The research record is narrower. NAD+ is a coenzyme involved in energy transfer and enzyme signaling [4]. Human trials show that NMN or NR can raise NAD+ in blood, and some studies report changes in walking performance, quality-of-life measures, or muscle insulin sensitivity [2][3][5]. Those outcomes do not prove age reversal, disease prevention, or longer life. Also, oral NAD+, oral precursors, and compounded infusions are different interventions; evidence for one should not be pasted onto another.
What is the downside of taking NAD+?
The first downside is uncertainty: blood NAD+ can rise without proving a meaningful clinical benefit [1]. Product format and quality also matter. Oral NAD+ has a different absorption rationale from NMN or NR, while compounded injectable products add manufacturing and contamination risks. Short precursor trials cannot establish long-term safety. The role of NAD+ in cancer biology is context-dependent because proliferating cells also use cellular energy and repair pathways. This site cannot determine personal risk or suitability; it reports why the broad wellness claim outruns the evidence.
Is it safe to take NAD daily?
The available corpus does not support a universal yes-or-no answer or a daily-use recommendation. Some controlled precursor studies reported no meaningful adverse-event difference from placebo during their study periods [2][5]. That is evidence about defined products, participants, and limited durations—not every NAD+-labeled product, route, health condition, or long-term exposure. Compounded injectable NAD+ is not equivalent to an oral precursor and carries additional quality-control concerns. A literature digest cannot turn short trial tolerability into individual medical guidance.
Does NAD cause weight gain?
The cited research does not establish NAD+ or its precursors as a cause of weight gain. In one NMN trial focused on muscle insulin sensitivity, body composition did not change [3]. That specific result should not be exaggerated in either direction: it does not show weight gain, and it does not establish a weight-loss effect. Body weight can change for many reasons, while NAD+ studies differ in formulation, population, and endpoint. The evidence here supports a narrow answer rather than a promise.
What is Epitalon?
Epitalon is a synthetic peptide made from four amino acids, commonly represented as AEDG. It is derived from the composition of Epithalamin, a bovine pineal extract, but the two are not identical. Laboratory research links Epitalon with telomerase activity, telomere length, and melatonin-related signaling [9][10][11]. A recent review describes several proposed geroprotective mechanisms while noting limited structural characterization and unresolved mechanism questions [8]. It has no approved human indication in major Western markets.
What are the benefits of Epitalon according to research?
The safest wording is observed effects in experimental models, not proven benefits. Human-cell studies report telomerase activation and telomere elongation [9][11]. Rat pineal-cell research reports increased activity in a melatonin-synthesis pathway [10]. An observational study of the related extract Epithalamin reported an association with reduced mortality, but it was not randomized or placebo-controlled and does not establish a causal effect of synthetic Epitalon [12]. Reports of improved sleep or vitality in longevity communities are anecdotal, not clinical evidence.
What is the recommended dosage of Epitalon in research protocols?
This site does not provide or recommend a human dose. Epitalon is unapproved for human use in major Western markets, lacks a settled human pharmacokinetic profile, and does not have a robust body of randomized human trials from which a responsible regimen could be derived [8]. Laboratory concentrations and historical experimental schedules answer questions about how a specific study was run; they are not instructions for self-administration. Turning them into a protocol would cross the line from evidence summary to unsafe medical advice.
How often should Epitalon be cycled, once or twice a year?
There is no evidence-based cycling schedule established by the corpus, so this digest does not endorse annual, twice-yearly, or any other use. The question assumes that repeated human use is effective and acceptably safe; those points have not been demonstrated. The core evidence remains largely mechanistic, cell-based, or observational [8][9][10][11][12]. Community cycle reports are anecdotal, not clinical evidence, and uncertain product identity adds another uncontrolled variable. A repeated-use schedule cannot be reverse-engineered responsibly from that record.